Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$618.46 USD

618.46
1,324,097

-5.75 (-0.92%)

Updated Sep 11, 2024 04:00 PM ET

After-Market: $618.47 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Trina Mukherjee headshot

4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021

Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.

HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates

HealthEquity (HQY) delivers strong growth in Service, Custodial and Interchange segments in Q3.

3 Reasons Growth Investors Will Love Thermo Fisher (TMO)

Thermo Fisher (TMO) is well positioned to outperform the market, as it exhibits above-average growth in financials.

QIAGEN (QGEN) Launches RUO Solution to Explore Immune Response

QIAGEN's (QGEN) latest RUO solution is expected to provide better insights into the course of the COVID-19 infection and aid in vaccine development and deployment.

LabCorp (LH) Covance Arms Shows Momentum Amid COVID-19 Woes

In oncology too, LabCorp (LH) receives a significant award to be the partner of choice for late-stage oncology studies from a major pharmaceutical company.

NuVasive (NUVA) Focuses on Cervical Spine Portfolio Expansion

The ACP system within NuVasive (NUVA) C360 is targeted to reduce common postoperative complications such as dysphagia, malalignment and adjacent level ossification.

Sweta Killa headshot

5 Top-Ranked Stocks With Solid Dividend Growth to Bet On

These dividend growth stocks have superior fundamentals, making them quality and promising investments for the long term.

Here's Why You Should Retain Change Healthcare (CHNG) Stock

Change Healthcare (CHNG) continues to benefit from robust payment accuracy business and strategic deals. However, intense competition remains a woe.

NextGen (NXGN) Reinforces Its Robust Solutions Portfolio

NextGen's (NXGN) solid solutions portfolio receives further boost with the success of its Population Health tool.

The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific

The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific

Veeva (VEEV) Vault Applications Get Adopted by GenesisCare

Veeva Systems' (VEEV) clinical capabilities will allow GenesisCare Clinical CRO to rationalize trial procedures and expedite execution of the same.

CVS Health (CVS) 2021 Selling Season Strong, LTC Arm Suffers

Since the start of the pandemic, CVS Health (CVS) is seeing more than 40% of all specialty orders being placed digitally.

Boston Scientific's (BSX) SCS Systems Receives FDA's Nod

Boston Scientific's (BSX) WaveWriter Alpha portfolio of SCS Systems aims to widen the therapy options available for managing chronic pain.

Baxter's (BAX) Vital Edge Program Aids Patient Blood Management

Baxter's (BAX) Vital Edge program enables AdventHealth Tampa to achieve cost savings.

Here's Why You Should Retain LHC Group (LHCG) Stock Now

LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

Urmimala Biswas headshot

3 Growth Stocks to Tap the COVID-Driven Shift in MedTech

To beat the pandemic blues and maximize capital gains, investors can now scoop up these fundamentally-strong MedTech growth stocks.

Abbott's (ABT) Libre 2 Cleared in Canada, Boosts CGM Prospects

Abbott's (ABT) next-generation FreeStyle Libre 2 system aims to provide a better quality of life to diabetics in Canada at the same affordable price of the current FreeStyle Libre system.

Cooper Companies (COO) Q4 Earnings & Revenues Top Estimates

Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.

Here's Why You Should Invest in Cardinal Health (CAH) Stock

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.

Why You Should Retain Pacific Biosciences (PACB) Stock Now

Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects.

Zimmer Biomet (ZBH) Boosts Portfolio With A&E Medical Buyout

This latest development aligns with Zimmer Biomet's (ZBH) active portfolio management strategy and the ongoing transformation of business aimed at long-term growth.

BD (BDX) to Boost Pre-Fillable Syringe-Manufacturing Capacity

BD (BDX) is set to improve its pre-fillable syringe-manufacturing ability with its expansion and upgrade plans.

Hologic's (HOLX) New AI Technology Now Available Post FDA Nod

Hologic's (HOLX) latest 3D CAD solution is expected to aid in early detection of breast cancer along with prioritizing the most concerning patient cases.

Veeva Systems (VEEV) Q3 Earnings and Revenues Beat Estimates

Veeva Systems' (VEEV) core Subscription Service and Professional Service segments deliver an impressive performance in Q3.

Patterson Companies (PDCO) Q2 Earnings Top Estimates, Up Y/Y

Patterson Companies' (PDCO) fiscal second-quarter 2021 results benefit from strong segmental performance.